Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11719)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 18, 2015 (publication date) through Nov 9, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Salem ML, El-Badawy A. Programmed death-1/programmed death-L1 signaling pathway and its blockade in hepatitis C virus immunotherapy. World J Hepatol 2015; 7(23): 2449-2458 [PMID: 26483866 DOI: 10.4254/wjh.v7.i23.2449] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i23/2449.htm |
| Number | Citing Articles |
| 1 |
Jacob C. Bjorgen, Jenna K. Dick, Ross Cromarty, Geoffrey T. Hart, Joshua Rhein. NK cell subsets and dysfunction during viral infection: a new avenue for therapeutics?. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1267774
|
| 2 |
Meihua Qiu, Yuqing Chen, Qiao Ye. Downregulation of the PD-1/PD-Ls pathway in peripheral cells correlates with asbestosis severity. BMC Pulmonary Medicine 2021; 21(1) doi: 10.1186/s12890-021-01531-5
|
| 3 |
Zhijuan Lin, Xing Chen, Zhifeng Li, Yiming Luo, Zhihong Fang, Bing Xu, Mingzhe Han, Andrzej T Slominski. PD-1 Antibody Monotherapy for Malignant Melanoma: A Systematic Review and Meta-Analysis. PLOS ONE 2016; 11(8): e0160485 doi: 10.1371/journal.pone.0160485
|
| 4 |
Ilya Tsimafeyeu, Rustem Gafanov, Svetlana Protsenko, Anna Semenova, Ani Oganesyan, Nurzhan Nurgaliyev, Sergei Krasny, Anastasia Bondarenko, Sufia Safina, Kristina Zakurdaeva. Nivolumab in patients with metastatic renal cell carcinoma and chronic hepatitis C virus infection. Cancer Immunology, Immunotherapy 2020; 69(6): 983 doi: 10.1007/s00262-020-02521-y
|
| 5 |
J. M. Sahler, C. R. Eade, C. Altier, J. C. March, Shelley M. Payne. Salmonella enterica Serovar Typhimurium Increases Functional PD-L1 Synergistically with Gamma Interferon in Intestinal Epithelial Cells via Salmonella Pathogenicity Island 2. Infection and Immunity 2018; 86(5) doi: 10.1128/IAI.00674-17
|
| 6 |
E. Cimini, V. Bordoni, A. Sacchi, U. Visco-Comandini, M. Montalbano, C. Taibi, R. Casetti, E. Lalle, G. D’Offizi, M.R. Capobianchi, C. Agrati. Intrahepatic Vγ9Vδ2 T-cells from HCV-infected patients show an exhausted phenotype but can inhibit HCV replication. Virus Research 2018; 243: 31 doi: 10.1016/j.virusres.2017.10.008
|
| 7 |
Ayesha Obaid, Anam Naz, Aqsa Ikram, Faryal Mehwish Awan, Abida Raza, Jamil Ahmad, Amjad Ali. Model of the adaptive immune response system against HCV infection reveals potential immunomodulatory agents for combination therapy. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-27163-0
|
| 8 |
Laura Wuyts, Annelies Janssens, Luisa Vonghia, Peter Michielsen, Jo Raskin, Ann Driessen, Stijn Van Hees, Sven Francque, Thomas Vanwolleghem. Nivolumab and anti-HCV activity, a case report. Acta Clinica Belgica 2021; 76(5): 392 doi: 10.1080/17843286.2020.1741897
|
| 9 |
Eirini Karamichali, Pelagia Foka, Georgia Papadopoulou, Domniki Loukaki-Gkountara, Konstantina Andresaki, Ioannis Koskinas, Urania Georgopoulou. Hepatitis Viruses Control Host Immune Responses by Modifying the Exosomal Biogenesis Pathway and Cargo. International Journal of Molecular Sciences 2022; 23(18): 10862 doi: 10.3390/ijms231810862
|
| 10 |
Kohei Fujita, Young Hak Kim, Osamu Kanai, Hironori Yoshida, Tadashi Mio, Toyohiro Hirai. Emerging concerns of infectious diseases in lung cancer patients receiving immune checkpoint inhibitor therapy. Respiratory Medicine 2019; 146: 66 doi: 10.1016/j.rmed.2018.11.021
|
| 11 |
Mona Sadeghalvad, Nima Rezaei. Encyclopedia of Infection and Immunity. 2022; : 481 doi: 10.1016/B978-0-12-818731-9.00171-3
|
| 12 |
Erin S Beck, Irene Cortese. Checkpoint inhibitors for the treatment of JC virus-related progressive multifocal leukoencephalopathy. Current Opinion in Virology 2020; 40: 19 doi: 10.1016/j.coviro.2020.02.005
|
| 13 |
Marco Tagliamento, Francesco Grossi, Sabrina Paolino, Erika Rijavec, Carlo Genova, Giovanni Rossi, Federica Biello, Andrea De Maria. Nivolumab Treatment in Advanced Lung Cancer Patient With Chronic Active Hepatitis C and Systemic Lupus Erythematosus. Immunotherapy 2019; 11(10): 873 doi: 10.2217/imt-2019-0025
|
| 14 |
Kristina Zakurdaeva, Ilya Tsimafeyeu. Immunotherapy in cancer patients with chronic hepatitis C viral infection. Journal of Cancer Research and Therapeutics 2023; 19(5): 1093 doi: 10.4103/jcrt.jcrt_2095_21
|
| 15 |
Shima Bastaki, Mahzad Irandoust, Armin Ahmadi, Mohammad Hojjat-Farsangi, Patrick Ambrose, Shahin Hallaj, Mahdi Edalati, Ghasem Ghalamfarsa, Gholamreza Azizi, Mehdi Yousefi, Hengameh Chalajour, Farhad Jadidi-Niaragh. PD-L1/PD-1 axis as a potent therapeutic target in breast cancer. Life Sciences 2020; 247: 117437 doi: 10.1016/j.lfs.2020.117437
|
| 16 |
Lodovica Zullo, Giovanni Rossi, Chiara Dellepiane, Marco Tagliamento, Angela Alama, Simona Coco, Luca Longo, Paolo Pronzato, Andrea De Maria, Carlo Genova. Safety and Efficacy of Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer: Focus on Challenging Populations. Immunotherapy 2021; 13(6): 509 doi: 10.2217/imt-2020-0226
|
| 17 |
Yu Liu, Chenhua Wu, Nannan Chen, Yang Li, Chunling Fan, Shangqi Zhao, Tongtong Bai, Zhibo Zhao, Jinwei Chen, Siyu Su, Zecai Zhang, Yulong Zhou, Zhanbo Zhu. PD-1 Blockade Restores the Proliferation of Peripheral Blood Lymphocyte and Inhibits Lymphocyte Apoptosis in a BALB/c Mouse Model of CP BVDV Acute Infection. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.727254
|
| 18 |
Xue Chen, Ann M. Bode, Zigang Dong, Ya Cao. The epithelial–mesenchymal transition (EMT) is regulated by oncoviruses in cancer. The FASEB Journal 2016; 30(9): 3001 doi: 10.1096/fj.201600388R
|
| 19 |
Itziar Ubillos, Joseph J. Campo, Pilar Requena, Maria Ome-Kaius, Sarah Hanieh, Honor Rose, Paula Samol, Diana Barrios, Alfons Jiménez, Azucena Bardají, Ivo Mueller, Clara Menéndez, Stephen Rogerson, Gemma Moncunill, Carlota Dobaño. Chronic Exposure to Malaria Is Associated with Inhibitory and Activation Markers on Atypical Memory B Cells and Marginal Zone-Like B Cells. Frontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.00966
|
| 20 |
Lydia Dyck, Kingston H.G. Mills. Immune checkpoints and their inhibition in cancer and infectious diseases. European Journal of Immunology 2017; 47(5): 765 doi: 10.1002/eji.201646875
|
| 21 |
Mohamed Labib Salem, Abdel-Aziz A. Zidan, Mohamed Attia, Randa E. EL-Naggar, Mohamed Nassef, Abdel Raouf Abou El-Azm, Hasan El-Bate, Mohamed Yussif, Sohaila Galal, Mohamed Abo Senna, Maha El Demellawy. IFN-α-based treatment of patients with chronic HCV show increased levels of cells with myeloid-derived suppressor cell phenotype and of IDO and NOS. Immunopharmacology and Immunotoxicology 2017; 39(4): 188 doi: 10.1080/08923973.2017.1320670
|
| 22 |
Yu Liu, Shanshan Liu, Boning He, Tian Wang, Shangqi Zhao, Chenhua Wu, Shan Yue, Shixun Zhang, Mingrui He, Li Wang, Wenjing Huang, Tongrui Shi, Zhanbo Zhu. PD-1 blockade inhibits lymphocyte apoptosis and restores proliferation and anti-viral immune functions of lymphocyte after CP and NCP BVDV infection in vitro. Veterinary Microbiology 2018; 226: 74 doi: 10.1016/j.vetmic.2018.10.014
|
| 23 |
Honggeng Guan, Yuqiu Wan, Jing Lan, Qin Wang, Zhangyu Wang, Yecheng Li, Jiqing Zheng, Xueguang Zhang, Zemin Wang, Yueping Shen, Fang Xie. PD-L1 is a critical mediator of regulatory B cells and T cells in invasive breast cancer. Scientific Reports 2016; 6(1) doi: 10.1038/srep35651
|
| 24 |
Yun-Chao Zhang, Yu-Ting Zhang, Yi Wang, Ya Zhao, Li-Jie He. What role does PDL1 play in EMT changes in tumors and fibrosis?. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1226038
|
| 25 |
Huiming Cai, Ge Liu, Jianfeng Zhong, Kai Zheng, Haitao Xiao, Chenyang Li, Xun Song, Ying Li, Chenshu Xu, Haiqiang Wu, Zhendan He, Qinchang Zhu. Immune Checkpoints in Viral Infections. Viruses 2020; 12(9): 1051 doi: 10.3390/v12091051
|
| 26 |
Yuan Liu. Immunomodulatory effects of Tim-3 and PD-1 on chronic hepatitis B virus infection. Infection International 2018; 7(1): 6 doi: 10.2478/ii-2018-0012
|
| 27 |
Samaneh Abdolmohammadi-Vahid, Behzad Baradaran, Ian M. Adcock, Esmaeil Mortaz. Immune checkpoint inhibitors and SARS-CoV2 infection. International Immunopharmacology 2024; 137: 112419 doi: 10.1016/j.intimp.2024.112419
|
| 28 |
Lei Sun, Kun Yang, Liang Zhang, Li-ming Qi, Jia-min Chen, Ping Li, Jiang Xiao, Hong-xin Zhao, Peng Wang. Programmed death-1 expression and regulatory T cells increase in the Intestinal mucosa of cytomegalovirus colitis in patients with HIV/AIDS. AIDS Research and Therapy 2020; 17(1) doi: 10.1186/s12981-020-00315-x
|
| 29 |
Jia Tang, Chenming Shang, Yue Chang, Wei Jiang, Jun Xu, Leidan Zhang, Lianfeng Lu, Ling Chen, Xiaosheng Liu, Qingjia Zeng, Wei Cao, Taisheng Li. Peripheral PD-1+NK cells could predict the 28-day mortality in sepsis patients. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1426064
|